共 50 条
- [21] 1-(3-Chlorophenyl)-2-methyl-4-nitro-1H-imidazole-5-carboxamide ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2626 - +
- [22] 1-[6-Chloro-4-(2-chlorophenyl)-2-methyl-3-quinolyl]ethanone ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O2002 - U1070
- [23] 1-[(3-Chlorophenyl)(morpholin-4-yl)methyl]naphthalen-2-ol ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1681 - U641
- [26] 3-(4-Chlorophenyl)-1-(2-methyl-4-phenylquinolin-3-yl)prop-2-en-1-one ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O621 - U1736
- [27] PHARMACODYNAMICS AND ANTITHROMBOTIC EFFECTS AFTER INTRAVENOUS ADMINISTRATION OF THE NEW THROMBOXANE A(2) RECEPTOR ANTAGONIST SODIUM 4-[[1-[[[(4-CHLOROPHENYL)SULFONYL]AMINO]METHYL]CYCLOPENTYL]METHYL]BENZENEACETATE ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1994, 44-2 (11): : 1203 - 1207
- [28] 2-(4-Chlorophenyl)-4-[1-(4-chlorophenyl)-3-methyl-1H-pyrazol-5-yl]-5-methyl-1H-pyrazol-3(2H)-one ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O2569 - U535
- [29] 4-amino-2-(p-chlorophenyl)-5-methyl-3,4-dihydro-2H-1,2,4-triazol-3-one ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2003, 59 : O964 - O966
- [30] 3-(p-Chlorophenyl)-4-phenyl-4,5-di-hydroisoxazole-5-spiro-2′-1′,2′,3′,4′-tetrahydronaphthalen-1′-one ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2001, 57 (07): : 819 - 820